Luping Lin

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations

Medicine, Cancer Biology, Oncology +16

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Luping Lin, Amit J. Sabnis, Elton Chan et al. · Nature Genetics · 2015 · 553 citations · Full text

Medicine, Cancer Biology, Oncology +14

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos et al. · Nature Medicine · 2015 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +16

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas et al. · Cell Reports · 2015 · 203 citations · Full text

Medicine, Cancer Biology, Oncology +15

Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer

Luping Lin, Saurabh Asthana, Elton Chan et al. · Proceedings of the National Academy of Sciences · 2014 · 107 citations · Full text

Medicine, Genetics, Oncology +14